期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
SARS-CoV-2/COVID-19 laboratory biosafety practices and current molecular diagnostic tools 被引量:1
1
作者 Raphael Nyaruaba Caroline Mwaliko +2 位作者 Wei Hong patrick amoth Hongping Wei 《Journal of Biosafety and Biosecurity》 2021年第2期131-140,共10页
The ongoing severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)/coronavirus disease 2019(COVID-19)pandemic has crippled several countries across the globe posing a serious global public health challenge.Despit... The ongoing severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)/coronavirus disease 2019(COVID-19)pandemic has crippled several countries across the globe posing a serious global public health challenge.Despite the massive rollout of vaccines,molecular diagnosis remains the most important method for timely isolation,diagnosis,and control of COVID-19.Several molecular diagnostic tools have been developed since the beginning of the pandemic with some even gaining emergency use authorization from the United States(US)Food and Drug Administration for in vitro diagnosis of SARS-CoV-2.Herein,we discuss the working principles of some commonly used molecular diagnostic tools for SARS-CoV-2 including nucleic acid amplification tests,isothermal amplification tests,and rapid diagnostic tests.To ensure successful detection while minimizing the risk of cross-infection and misdiagnosis when using these diagnostic tools,laboratories should adhere to proper biosafety practices.Hence,we also present the common biosafety practices that may ensure the successful detection of SARS-CoV-2 from specimens while protecting laboratory workers and non-suspecting individuals from being infected.From this review article,it is clear that the SARS-CoV-2 pandemic has led to an increase in molecular diagnostic tools and the formation of new biosafety protocols that may be important for future and ongoing outbreaks. 展开更多
关键词 BIOSAFETY RDTs NAATs RT-PCR IATs COVID-19 SARS-CoV-2 DIAGNOSIS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部